Total Payments
$3,954
2023 Payments
$125.74
Companies
22
Transactions
142
Medicare Patients
4,139
Medicare Billing
$426,057
Payment Breakdown by Category
Food & Beverage$3,954 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,954 | 142 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $893.29 | 33 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $774.69 | 18 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $636.07 | 18 | $0 (2018) |
| Inspire Medical Systems, Inc. | $369.04 | 2 | $0 (2023) |
| Respiratory Technologies, Inc. | $366.97 | 18 | $0 (2017) |
| Philips Electronics North America Corporation | $201.83 | 8 | $0 (2018) |
| Sunovion Pharmaceuticals Inc. | $154.23 | 15 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $71.76 | 3 | $0 (2017) |
| Actelion Pharmaceuticals US, Inc. | $68.41 | 4 | $0 (2017) |
| Resmed Corp | $58.33 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $125.74 | 1 | Inspire Medical Systems, Inc. ($125.74) |
| 2022 | $243.30 | 1 | Inspire Medical Systems, Inc. ($243.30) |
| 2020 | $20.54 | 1 | Sunovion Pharmaceuticals Inc. ($20.54) |
| 2019 | $326.43 | 3 | Boehringer Ingelheim Pharmaceuticals, Inc. ($201.84) |
| 2018 | $682.13 | 13 | AstraZeneca Pharmaceuticals LP ($348.65) |
| 2017 | $2,556 | 123 | GlaxoSmithKline, LLC. ($641.12) |
All Payment Transactions
142 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/24/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $125.74 | General |
| Category: NEUROLOGY | ||||||
| 06/08/2022 | Inspire Medical Systems, Inc. | Inspire Upper Airway Stimulation System (Device) | Food and Beverage | Cash or cash equivalent | $243.30 | General |
| Category: Neurology | ||||||
| 06/24/2020 | Sunovion Pharmaceuticals Inc. | UTIBRON NEOHALER (Drug), SEEBRI NEOHALER, LONHALA MAGNAIR | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Respiratory | ||||||
| 12/05/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $76.84 | General |
| 04/02/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 02/06/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $124.59 | General |
| Category: RESPIRATORY | ||||||
| 10/29/2018 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $2.58 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2018 | Philips Electronics North America Corporation | Wellcentive Undiv (Device) | Food and Beverage | Cash or cash equivalent | $8.18 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/18/2018 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 07/18/2018 | Philips Electronics North America Corporation | Wellcentive Undiv (Device) | Food and Beverage | Cash or cash equivalent | $97.09 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/21/2018 | Philips Electronics North America Corporation | Wellcentive Undiv (Device) | Food and Beverage | Cash or cash equivalent | $1.92 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/17/2018 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $98.65 | General |
| Category: Respiratory | ||||||
| 05/10/2018 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $44.72 | General |
| Category: HFCWO | ||||||
| 04/30/2018 | Philips Electronics North America Corporation | Wellcentive Undiv (Device) | Food and Beverage | Cash or cash equivalent | $32.98 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/19/2018 | Philips Electronics North America Corporation | Wellcentive Undiv (Device) | Food and Beverage | Cash or cash equivalent | $4.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/05/2018 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RESPIRATORY | ||||||
| 02/27/2018 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 02/14/2018 | Philips Electronics North America Corporation | Respiratoriy Care Undiv (Device) | Food and Beverage | Cash or cash equivalent | $13.02 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/08/2018 | Philips Electronics North America Corporation | Respiratoriy Care Undiv (Device) | Food and Beverage | Cash or cash equivalent | $3.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/18/2017 | Sunovion Pharmaceuticals Inc. | SEEBRI (Drug) | Food and Beverage | In-kind items and services | $1.04 | General |
| Category: RESPIRATORY | ||||||
| 12/14/2017 | Philips Electronics North America Corporation | Trilogy 100 (Device) | Food and Beverage | Cash or cash equivalent | $40.65 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/14/2017 | Respiratory Technologies, Inc. | — | Food and Beverage | Cash or cash equivalent | $24.00 | General |
| Category: Airway Clearance Therapy | ||||||
| 12/05/2017 | Sunovion Pharmaceuticals Inc. | SEEBRI (Drug) | Food and Beverage | In-kind items and services | $3.37 | General |
| Category: RESPIRATORY | ||||||
| 11/30/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $115.29 | General |
| 11/30/2017 | Sunovion Pharmaceuticals Inc. | SEEBRI (Drug) | Food and Beverage | In-kind items and services | $2.70 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,278 | 1,892 | $365,328 | $124,499 |
| 2022 | 16 | 1,219 | 1,668 | $343,864 | $120,857 |
| 2021 | 16 | 856 | 1,197 | $276,500 | $99,806 |
| 2020 | 18 | 786 | 1,134 | $239,788 | $80,896 |
Total Patients
4,139
Total Services
5,891
Medicare Billing
$426,057
Procedure Codes
69
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 201 | 354 | $94,872 | $36,510 | 38.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 254 | 344 | $62,608 | $23,976 | 38.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 79 | 243 | $44,712 | $15,942 | 35.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 84 | 84 | $34,860 | $11,004 | 31.6% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 128 | 220 | $23,100 | $4,800 | 20.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 30 | 32 | $15,616 | $4,625 | 29.6% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 87 | 91 | $14,105 | $4,350 | 30.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 31 | $11,160 | $4,146 | 37.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 38 | $10,032 | $3,769 | 37.6% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 74 | 77 | $12,012 | $3,527 | 29.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 16 | 16 | $8,240 | $2,382 | 28.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 15 | 16 | $5,328 | $1,702 | 31.9% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 50 | 114 | $5,426 | $1,625 | 29.9% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 44 | 47 | $5,358 | $1,549 | 28.9% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 48 | 48 | $4,146 | $1,372 | 33.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 41 | 41 | $7,257 | $1,336 | 18.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $4,495 | $1,237 | 27.5% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 13 | 13 | $1,599 | $492.44 | 30.8% |
| 85018 | Blood count, hemoglobin | Office | 2023 | 64 | 67 | $402.00 | $155.44 | 38.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 231 | 412 | $110,416 | $42,163 | 38.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 180 | 214 | $38,948 | $14,935 | 38.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 85 | 220 | $40,480 | $13,236 | 32.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 61 | 61 | $31,415 | $11,009 | 35.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 60 | 60 | $24,900 | $7,767 | 31.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 32 | 37 | $18,056 | $6,076 | 33.7% |
About Dr. Eric Gentry, MD
Dr. Eric Gentry, MD is a Pulmonary Disease healthcare provider based in Fairfield, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1134200827.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Gentry, MD has received a total of $3,954 in payments from pharmaceutical and medical device companies, with $125.74 received in 2023. These payments were reported across 142 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($3,954).
As a Medicare-enrolled provider, Gentry has provided services to 4,139 Medicare beneficiaries, totaling 5,891 services with total Medicare billing of $426,057. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Critical Care Medicine, Internal Medicine
- Location Fairfield, CT
- Active Since 10/18/2006
- Last Updated 05/31/2013
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1134200827
Products in Payments
- ANORO (Drug) $332.54
- INCRUSE (Drug) $245.03
- Inspire Upper Airway Stimulation System (Device) $243.30
- BEVESPI AEROSPHERE (Drug) $225.50
- FASENRA (Drug) $223.65
- SYMBICORT (Drug) $186.92
- Wellcentive Undiv (Device) $144.76
- BREO (Drug) $132.13
- INSPIRE (Device) $125.74
- TRELEGY ELLIPTA (Drug) $124.59
- UTIBRON (Drug) $115.48
- OFEV (Drug) $110.89
- STIOLTO (Drug) $97.11
- XOLAIR (Biological) $71.76
- OPSUMIT MACITENTAN (Drug) $68.41
- NUCALA (Biological) $59.00
- AirCurve (Device) $58.33
- Xyrem (Drug) $57.60
- Xolair (Biological) $46.67
- SMARTVEST (Device) $44.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Fairfield
Philip Greenspan, Md, MD
Pulmonary Disease — Payments: $41,849
Pulmonary Disease $41,849
Dr. Pradeep Lakshminarayana, M D, M D
Pulmonary Disease — Payments: $8,226
Pulmonary Disease $8,226
Gregory Colangelo, M.d, M.D
Pulmonary Disease — Payments: $7,625
Pulmonary Disease $7,625
Dr. Stasia Wieber, Md, MD
Pulmonary Disease — Payments: $1,515
Pulmonary Disease $1,515
Donald Doyle, Md, MD
Pulmonary Disease — Payments: $1,194
Pulmonary Disease $1,194